Correlation Between Korea Ratings and NeoPharm

Can any of the company-specific risk be diversified away by investing in both Korea Ratings and NeoPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korea Ratings and NeoPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Korea Ratings Co and NeoPharm LTD, you can compare the effects of market volatilities on Korea Ratings and NeoPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korea Ratings with a short position of NeoPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korea Ratings and NeoPharm.

Diversification Opportunities for Korea Ratings and NeoPharm

-0.44

Correlation Coefficient

Korea Ratings  NeoPharm

Very good diversification

The 3 months correlation between Korea and NeoPharm is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Korea Ratings Co and NeoPharm LTD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeoPharm LTD and Korea Ratings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korea Ratings Co are associated (or correlated) with NeoPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeoPharm LTD has no effect on the direction of Korea Ratings i.e., Korea Ratings and NeoPharm go up and down completely randomly.

Pair Corralation between Korea Ratings and NeoPharm

Assuming the 90 days trading horizon Korea Ratings Co is expected to generate 0.34 times more return on investment than NeoPharm. However, Korea Ratings Co is 2.91 times less risky than NeoPharm. It trades about 0.11 of its potential returns per unit of risk. NeoPharm LTD is currently generating about 0.01 per unit of risk. If you would invest  8,710,000  in Korea Ratings Co on September 22, 2024 and sell it today you would earn a total of  160,000  from holding Korea Ratings Co or generate 1.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Korea Ratings Co  vs.  NeoPharm LTD

Korea Ratings

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Korea Ratings Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Korea Ratings is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

NeoPharm LTD

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NeoPharm LTD are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, NeoPharm is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Korea Ratings and NeoPharm

The main advantage of trading using opposite Korea Ratings and NeoPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korea Ratings position performs unexpectedly, NeoPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoPharm will offset losses from the drop in NeoPharm's long position.

The idea behind Korea Ratings Co and NeoPharm LTD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.